rs1488467
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000472766.1(CAV3):n.156-5932G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0638 in 152,172 control chromosomes in the GnomAD database, including 323 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.064 ( 323 hom., cov: 33)
Consequence
CAV3
ENST00000472766.1 intron
ENST00000472766.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.165
Publications
15 publications found
Genes affected
CAV3 (HGNC:1529): (caveolin 3) This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites. [provided by RefSeq, Jul 2008]
CAV3 Gene-Disease associations (from GenCC):
- caveolinopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant limb-girdle muscular dystrophy type 1CInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- long QT syndrome 9Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- rippling muscle disease 2Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- distal myopathy, Tateyama typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- inherited rippling muscle diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Brugada syndromeInheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
- hypertrophic cardiomyopathy 1Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia
- long QT syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CAV3 | ENST00000472766.1 | n.156-5932G>C | intron_variant | Intron 1 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0638 AC: 9702AN: 152054Hom.: 324 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
9702
AN:
152054
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0638 AC: 9706AN: 152172Hom.: 323 Cov.: 33 AF XY: 0.0621 AC XY: 4621AN XY: 74386 show subpopulations
GnomAD4 genome
AF:
AC:
9706
AN:
152172
Hom.:
Cov.:
33
AF XY:
AC XY:
4621
AN XY:
74386
show subpopulations
African (AFR)
AF:
AC:
2516
AN:
41522
American (AMR)
AF:
AC:
928
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
396
AN:
3470
East Asian (EAS)
AF:
AC:
574
AN:
5176
South Asian (SAS)
AF:
AC:
278
AN:
4828
European-Finnish (FIN)
AF:
AC:
326
AN:
10586
Middle Eastern (MID)
AF:
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4480
AN:
68002
Other (OTH)
AF:
AC:
159
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
470
941
1411
1882
2352
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
293
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.